Zobrazeno 1 - 10 of 16 pro vyhledávání: '"Jasmina I. Radeva"'
1
Geographic Variation in the Prescription of Schedule II Opioid Analgesics among Outpatients in the United States
Autor: Jennifer Stoddard, Kevin A. Schulman, Alan Wright, Jasmina I. Radeva, Lesley H. Curtis, Raymond L. Woosley, Steve Hutchison, Peter E. Dans
Publikováno v: Health Services Research. 41:837-855
Effective management of pain often requires the use of opioid analgesics (American Pain Society 1999, 2002; World Health Organization 2000; American Pain Society 2004). Because of their potential for abuse, opioid analgesics are regulated under feder
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a0026cd961f53ecdfaff36fe31ab283
https://doi.org/10.1111/j.1475-6773.2006.00511.x
Zobrazit plný text záznamu
2
Early hemoglobin response and alternative metrics of efficacy with erythropoietic agents for chemotherapy-related anemia
Autor: Davey B Daniel, John Fastenau, Shelby D. Reed, Kevin A. Schulman, Jasmina I. Radeva, Denise Williams
Publikováno v: Current Medical Research and Opinion. 21:1527-1533
To examine associations between early hemoglobin response and alternative measures of efficacy following treatment with an erythropoietic agent for chemotherapy-related anemia.Preliminary data from an ongoing randomized, multicenter, 16-week, open-la
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96c293838bc5b6c0d119d77609bb22a0
https://doi.org/10.1185/030079905x65394
Zobrazit plný text záznamu
3
National estimates of the use of hematopoietic stem-cell transplantation in children with cancer in the United States
Autor: P P Breitfeld, E VanScoyoc, Lesley H. Curtis, Franklin O. Smith, Jasmina I. Radeva
Publikováno v: Bone Marrow Transplantation. 36:397-404
National utilization data for hematopoietic stem-cell transplantation (HSCT) for childhood cancers in the United States have not been reported. We identified cancer encounters for children aged 18 years and younger from 1997 to 2001 in US nonfederal,
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d9ef68ae607aa8e1c38f53f098140f4
https://doi.org/10.1038/sj.bmt.1705077
Zobrazit plný text záznamu
4
COST-EFFECTIVENESS OF ZOLEDRONIC ACID FOR THE PREVENTION OF SKELETAL COMPLICATIONS IN PATIENTS WITH PROSTATE CANCER
Autor: G. Alastair Glendenning, Fred Saad, Jasmina I. Radeva, Shelby D. Reed, Kevin A. Schulman
Publikováno v: Journal of Urology. 171:1537-1542
We estimated the cost-effectiveness of zoledronic acid vs placebo for decreasing skeletal complications in men with prostate cancer.We performed a cost-effectiveness analysis alongside a multinational clinical trial of zoledronic acid. Cost estimatio
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b95a9fb3e107a1c5b86ceacd9cb8472c
https://doi.org/10.1097/01.ju.0000116777.94426.60
Zobrazit plný text záznamu
5
Prevalence, referral patterns, testing, and surgery in aortic valve disease: leaving women and elderly patients behind?
Autor: David S, Bach, Jasmina I, Radeva, Howard G, Birnbaum, Andrée-Anne, Fournier, Edward G, Tuttle
Publikováno v: The Journal of heart valve disease. 16(4)
The prevalence of aortic valve disease is not well defined, and it is not known to what degree gender and age affect testing and surgery for this condition. The study aim was to describe the prevalence of aortic valve disease in the United States pop
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::d92f02664b3382d2dc37a54c3078c404
https://pubmed.ncbi.nlm.nih.gov/17702360
Zobrazit plný text záznamu
6
Correction to 'Geographic Variation in the Prescription of Schedule II Opioid Analgesics among Outpatients in the United States'
Autor: Kevin A. Schulman, Jasmina I. Radeva, Jennifer Stoddard, Peter E. Dans, Alan Wright, Steve Hutchison, Lesley H. Curtis, Raymond L. Woosley
In this issue of HSR, we report findings from our analysis of geographic variations in the prescription of Schedule II opioid analgesics in the United States (Curtis et al. 2006). We write now to inform HSR readers of inaccuracies in the report. It h
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f23454a06caabe110f397b3748cf748
https://europepmc.org/articles/PMC1713208/
Zobrazit plný text záznamu
7
Economic evaluation of weekly epoetin alfa versus biweekly darbepoetin alfa for chemotherapy-induced anaemia: evidence from a 16-week randomised trial
Autor: Davey B Daniel, Kevin A. Schulman, Shelby D. Reed, Samir H. Mody, Jamie B. Forlenza, R. Scott McKenzie, Jasmina I. Radeva
Publikováno v: PharmacoEconomics. 24(5)
Introduction: A 16-week, open-label, multicentre, randomised trial of weekly epoetin alfa 40 000 units versus biweekly darbepoetin alfa 200µg among 358 patients with solid-tumour cancers and chemotherapy-induced anaemia demonstrated superior haemato
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc664e076a4cbeb249dd820ea5ced486
https://pubmed.ncbi.nlm.nih.gov/16706573
Zobrazit plný text záznamu
8
Economic evaluation of valsartan in patients with chronic heart failure: Results from Val-HeFT adapted to the Netherlands
Autor: Jasmina I. Radeva, Adriaan A. Voors, Maarten J. Postma, Cornelis Boersma, Marc A. Koopmanschap
Publikováno v: Journal of Medical Economics, 9(121-131), 121-131. Taylor & Francis Ltd
Journal of Medical Economics, 9, 121-131. Taylor & Francis Ltd
The Valsartan Heart Failure Trial (Val-HeFT) was a multinational randomised trial of valsartan versus placebo in a total of 5,010 patients with heart failure. During the study period, valsartan resulted in significant reductions in hospitalisations d
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::979337382f3fe643b0b9137c09b66199
https://research.rug.nl/en/publications/222b4d93-a0c2-4d38-8bfc-debdf1f97f36
Zobrazit plný text záznamu
9
Economic evaluation of everolimus vs. azathioprine at one year after de novo heart transplantation
Autor: Teresa L. Kauf, Jasmina I. Radeva, Nathalie Cretin, Zoltán Kaló, Shelby D. Reed, Edward Cantu, Kevin A. Schulman
Publikováno v: Clinical transplantation. 19(1)
Background: Everolimus decreases acute rejection and cardiac allograft vasculopathy after heart transplantation. We compared within-trial costs and resource use over 1 yr of follow-up in de novo heart transplant patients randomized to everolimus 1.5
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a28ae2cabe87c062517e87b9ed0f3b40
https://pubmed.ncbi.nlm.nih.gov/15659145
Zobrazit plný text záznamu
10
Resource use, costs, and quality of life among patients in the multinational Valsartan in Acute Myocardial Infarction Trial (VALIANT)
Autor: Jasmina I. Radeva, Kevin P. Weinfurt, Mary Ann Sellers, Leah E. Masselink, Marc A. Pfeffer, Robert M. Califf, Eric J. Velazquez, Jennifer S. Allsbrook, Shelby D. Reed, John J.V. McMurray, Kevin A. Schulman
Publikováno v: American heart journal. 150(2)
Background In a multinational clinical trial, valsartan was statistically not inferior to captopril in reducing mortality and cardiovascular morbidity after myocardial infarction (MI) in patients with signs of heart failure and/or left ventricular dy
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb71c923f7ee4bbd6a534726f5ead512
https://pubmed.ncbi.nlm.nih.gov/16086938
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje